MATINAS BIOPHARMA HOLDINGS, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $104.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $104.00K, a 56.30% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $113.00K, a 64.13% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-12-31 was $217.00K, a 11.07% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $253.00K, a 73.78% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $1.02M, a 67.98% decline from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $3.19M, a 35.43% decline from fiscal 2023.
- MATINAS BIOPHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $4.95M, a 5.36% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $5.23M, a 24.71% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month as first filed | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $104.00K 10-Q · filed 2026-08-13 | $217.00K 10-Q · filed 2026-08-13 | $434.00K derived: sum of 3 quarters · filed 2026-08-13 | $687.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $113.00K 10-Q · filed 2026-05-08 | $330.00K derived: sum of 2 quarters · filed 2026-05-08 | $583.00K derived: sum of 3 quarters · filed 2026-05-08 | $821.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $470.00K derived: sum of 2 quarters · filed 2026-03-31 | $708.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.02M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $253.00K 10-Q · filed 2025-11-10 | $491.00K derived: sum of 2 quarters · filed 2026-08-13 | $806.00K 10-Q · filed 2025-11-10 | $1.05M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $238.00K 10-Q · filed 2026-08-13 | $553.00K 10-Q · filed 2026-08-13 | $797.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.76M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $315.00K 10-Q · filed 2026-05-08 | $559.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.52M derived: sum of 3 quarters · filed 2026-05-08 | $2.52M derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.21M derived: sum of 2 quarters · filed 2026-03-31 | $2.20M derived: sum of 3 quarters · filed 2026-03-31 | $3.19M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $965.00K 10-Q · filed 2025-11-10 | $1.96M derived: sum of 2 quarters · filed 2025-11-10 | $2.95M 10-Q · filed 2025-11-10 | $4.22M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $991.00K 10-Q · filed 2025-08-14 | $1.99M 10-Q · filed 2025-08-14 | $3.26M derived: sum of 3 quarters · filed 2025-08-14 | $4.45M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $995.00K 10-Q · filed 2025-05-15 | $2.27M derived: sum of 2 quarters · filed 2025-05-15 | $3.46M derived: sum of 3 quarters · filed 2025-05-15 | $4.67M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $2.47M derived: sum of 2 quarters · filed 2025-04-15 | $3.68M derived: sum of 3 quarters · filed 2025-04-15 | $4.95M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $1.20M 10-Q · filed 2024-11-13 | $2.40M derived: sum of 2 quarters · filed 2024-11-13 | $3.68M 10-Q · filed 2024-11-13 | $5.02M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $1.21M 10-Q · filed 2024-08-14 | $2.48M 10-Q · filed 2024-08-14 | $3.82M derived: sum of 3 quarters · filed 2024-08-14 | $5.23M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $1.27M 10-Q · filed 2024-05-09 | $2.61M derived: sum of 2 quarters · filed 2024-05-09 | $4.03M derived: sum of 3 quarters · filed 2024-05-09 | $5.24M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.75M derived: sum of 2 quarters · filed 2024-03-27 | $3.97M derived: sum of 3 quarters · filed 2024-03-27 | $5.23M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $1.41M 10-Q · filed 2023-11-08 | $1.41M 10-Q · filed 2022-11-02 | $2.63M derived: sum of 2 quarters · filed 2023-11-08 | $3.89M 10-Q · filed 2023-11-08 | $3.89M 10-Q · filed 2022-11-02 | $4.95M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $1.22M 10-Q · filed 2023-08-09 | $1.21M 10-Q · filed 2022-08-11 | $2.48M 10-Q · filed 2023-08-09 | $2.47M 10-Q · filed 2022-08-11 | $3.53M derived: sum of 3 quarters · filed 2023-08-09 | $4.57M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $1.26M 10-Q · filed 2023-05-10 | $1.26M 10-Q · filed 2022-05-12 | $2.32M derived: sum of 2 quarters · filed 2023-05-10 | $3.35M derived: sum of 3 quarters · filed 2023-05-10 | $4.38M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $2.09M derived: sum of 2 quarters · filed 2023-03-15 | $3.12M derived: sum of 3 quarters · filed 2023-03-15 | $4.19M 10-K · filed 2023-03-15 | $4.19M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $1.03M 10-Q · filed 2022-11-02 | $2.06M derived: sum of 2 quarters · filed 2022-11-02 | $3.13M 10-Q · filed 2022-11-02 | $4.23M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $1.03M 10-Q · filed 2022-08-11 | $2.10M 10-Q · filed 2022-08-11 | $3.20M derived: sum of 3 quarters · filed 2022-08-11 | $4.07M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $1.07M 10-Q · filed 2022-05-12 | $2.18M derived: sum of 2 quarters · filed 2022-05-12 | $3.04M derived: sum of 3 quarters · filed 2022-05-12 | $3.89M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $1.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $1.97M derived: sum of 2 quarters · filed 2022-03-11 | $2.82M derived: sum of 3 quarters · filed 2022-03-11 | $4.18M 10-K/A · filed 2022-03-11 | ||||
| 2020-09-30 | $863.52K 10-Q · filed 2021-11-08 | $1.71M derived: sum of 2 quarters · filed 2021-11-08 | $3.08M 10-Q · filed 2021-11-08 | $3.65M derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | $850.88K 10-Q · filed 2021-08-10 | $2.22M 10-Q · filed 2021-08-10 | $2.78M derived: sum of 3 quarters · filed 2021-08-10 | $3.39M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $1.37M 10-Q · filed 2021-05-10 | $1.93M derived: sum of 2 quarters · filed 2021-05-10 | $2.54M derived: sum of 3 quarters · filed 2021-05-10 | $3.31M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $565.82K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $1.17M derived: sum of 2 quarters · filed 2021-03-29 | $1.94M derived: sum of 3 quarters · filed 2021-03-29 | $2.63M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $608.13K 10-Q · filed 2020-11-06 | $1.37M derived: sum of 2 quarters · filed 2020-11-06 | $2.06M 10-Q · filed 2020-11-06 | $2.96M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $763.50K 10-Q · filed 2020-08-10 | $1.45M 10-Q · filed 2020-08-10 | $2.35M derived: sum of 3 quarters · filed 2020-08-10 | $2.71M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $687.74K 10-Q · filed 2020-05-11 | $1.59M derived: sum of 2 quarters · filed 2020-05-11 | $1.95M derived: sum of 3 quarters · filed 2020-05-11 | $2.33M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $899.51K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $1.26M derived: sum of 2 quarters · filed 2020-03-09 | $1.64M derived: sum of 3 quarters · filed 2020-03-09 | $3.22M 10-K · filed 2020-03-09 | ||||
| 2018-09-30 | $361.60K 10-Q · filed 2019-11-13 | $741.84K derived: sum of 2 quarters · filed 2019-11-13 | $2.32M 10-Q · filed 2019-11-13 | $3.15M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $380.24K 10-Q · filed 2019-08-13 | $1.96M 10-Q · filed 2019-08-13 | $2.79M derived: sum of 3 quarters · filed 2019-08-13 | |||||
| 2018-03-31 | $1.58M 10-Q · filed 2019-05-13 | $2.41M derived: sum of 2 quarters · filed 2019-05-13 | ||||||
| 2017-12-31 | $829.73K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $2.45M 10-K · filed 2019-04-01 | ||||||
| 2017-09-30 | $1.62M 10-Q · filed 2017-11-14 | |||||||
| 2016-12-31 | $1.22M 10-K · filed 2018-03-16 | $1.22M 10-K · filed 2017-03-31 | ||||||
| 2015-12-31 | $1.35M 10-K · filed 2018-03-16 | |||||||
| 2015-03-31 | $332.68K 10-Q · filed 2015-05-15 | |||||||
| 2014-12-31 | $1.82M 10-K · filed 2017-03-31 | |||||||
| 2013-12-31 | $211.04K 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |